For: | Adali G, Yorulmaz E, Ozkanli S, Ulasoglu C, Bayraktar B, Orhun A, Colak Y, Tuncer I. Serum concentrations of insulin-like growth factor-binding protein 5 in Crohn’s disease. World J Gastroenterol 2013; 19(47): 9049-9056 [PMID: 24379630 DOI: 10.3748/wjg.v19.i47.9049] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v19/i47/9049.htm |
Number | Citing Articles |
1 |
Calen A. Steiner, Jeffrey A. Berinstein, Jeremy Louissaint, Peter D.R. Higgins, Jason R. Spence, Carol Shannon, Cathy Lu, Ryan W. Stidham, Joel G. Fletcher, David H. Bruining, Brian G. Feagan, Vipul Jairath, Mark E. Baker, Dominik Bettenworth, Florian Rieder. Biomarkers for the Prediction and Diagnosis of Fibrostenosing Crohn’s Disease: A Systematic Review. Clinical Gastroenterology and Hepatology 2022; 20(4): 817 doi: 10.1016/j.cgh.2021.05.054
|
2 |
Leon A. Bach. Insulin-like growth factor binding proteins 4-6. Best Practice & Research Clinical Endocrinology & Metabolism 2015; 29(5): 713 doi: 10.1016/j.beem.2015.06.002
|